Literature DB >> 33678164

Evaluation of static and dynamic Pupillometry changes in men using Silodosin for benign prostatic hypertrophy.

Umut Karaca1, Engin Kaya2, Onder Ayyildiz3, Gokhan Ozge3, Murat Kucukevcilioglu3, Gulsah Usta4, Fatih Mehmet Mutlu3.   

Abstract

BACKGROUND: Intraoperative floppy iris syndrome is a variant of the small pupil syndrome that has been observed during cataract surgery in some patients currently or previously treated with α1 adrenergic blockers. It is important for cataract surgeons to predict the probable complications preoperatively. Our study aims to evaluate the static and dynamic pupil characteristics of patients treated with silodosin-a selective α1 adrenergic blocker-for benign prostate hypertrophy (BPH) and to compare these values with healthy subjects using an automatic quantitative pupillometry system.
METHODS: A total of 74 BPH patients treated with silodosin for six months (group 1) and 30 healthy subjects (group 2) were enrolled in this prospective multidisciplinary cross-sectional study. Static and dynamic pupillometric measurements were obtained under optimized conditions, and the results were compared between the two groups.
RESULTS: Seventy-four male patients with a mean age of 63,35 ± 7,21 (46-77) years with BPH treated with silodosin and 30 normal male subjects with a mean age of 63,07 ± 4,73 (52-71) years were analyzed. There were statistically significant differences between the groups with regard to scotopic pupil diameter (PD), high photopic PD, and low photopic PD (p < 0.001, for each one). The patient group had statistically significant higher values of amplitude and velocity of pupil contraction and lower values of duration of pupil contraction and latency as well as duration and velocity of pupil dilation.
CONCLUSION: The static and dynamic pupil characteristics of subjects treated with silodosin for BPH are different from those of healthy eyes. In addition, our results may have shed light on the risk for intraoperative floppy iris syndrome (IFIS) before cataract surgery; thus, surgeons can be alert and take precautions.

Entities:  

Keywords:  Automated pupillometry; Benign prostatic hypertrophia; Intraoperative floppy iris syndrome; Silodosin; α1 adrenergic antagonists

Mesh:

Substances:

Year:  2021        PMID: 33678164      PMCID: PMC7938558          DOI: 10.1186/s12886-021-01894-7

Source DB:  PubMed          Journal:  BMC Ophthalmol        ISSN: 1471-2415            Impact factor:   2.209


  23 in total

1.  Silodosin, a new alpha1A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men.

Authors:  Kazuki Kawabe; Masaki Yoshida; Yukio Homma
Journal:  BJU Int       Date:  2006-08-31       Impact factor: 5.588

2.  In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits.

Authors:  Martin C Michel; Hiroko Okutsu; Yukiko Noguchi; Masanori Suzuki; Akiyoshi Ohtake; Hironori Yuyama; Hiroko Yanai-Inamura; Masashi Ukai; Mai Watanabe; Akiyoshi Someya; Masao Sasamata
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-18       Impact factor: 3.000

3.  Dynamic pupillometry as an autonomic testing tool.

Authors:  Srikanth Muppidi; Beverley Adams-Huet; Emil Tajzoy; Maggie Scribner; Paul Blazek; Elaine B Spaeth; Elliott Frohman; Scott Davis; Steven Vernino
Journal:  Clin Auton Res       Date:  2013-07-24       Impact factor: 4.435

4.  Pupillometric evaluation of the dynamics of the pupillary response to a brief light stimulus in healthy subjects.

Authors:  Fion D Bremner
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-23       Impact factor: 4.799

5.  Reproducibility and normal values of static pupil diameters.

Authors:  Simon Schröder; Ekaterina Chashchina; Edgar Janunts; Alan Cayless; Achim Langenbucher
Journal:  Eur J Ophthalmol       Date:  2018-03       Impact factor: 2.597

6.  Preoperative ocular characteristics predicting the development of intraoperative floppy iris syndrome regardless of alpha-antagonist exposure status.

Authors:  Margarita Safir; Idan Hecht; Morris E Hartstein; Oron Mahler; Adi Einan-Lifshitz; Eran Pras
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-11       Impact factor: 3.117

Review 7.  [Efficiency and safety of silodosin for treatment of lower urinary tract symptoms, associated of benign prostatic hyperplasia].

Authors:  G G Krivoborodov; E I Tur
Journal:  Urologiia       Date:  2019-06

Review 8.  alpha(1)-Adrenergic receptor antagonists and the iris: new mechanistic insights into floppy iris syndrome.

Authors:  Debra A Schwinn; Natalie A Afshari
Journal:  Surv Ophthalmol       Date:  2006 Sep-Oct       Impact factor: 6.048

9.  Effects of tamsulosin and silodosin on isolated albino and pigmented rabbit iris dilators: possible mechanism of intraoperative floppy-iris syndrome.

Authors:  Toshiaki Goseki; Hitoshi Ishikawa; Shiori Ogasawara; Kimiyo Mashimo; Noriko Nemoto; Yuko Taguchi; Kazuo Yago; Kimiya Shimizu
Journal:  J Cataract Refract Surg       Date:  2012-07-11       Impact factor: 3.351

10.  Evaluation of pupillary response to light in patients with glaucoma: a study using computerized pupillometry.

Authors:  Alessio Martucci; Massimo Cesareo; Domenico Napoli; Roberto Pietro Sorge; Federico Ricci; Raffaele Mancino; Carlo Nucci
Journal:  Int Ophthalmol       Date:  2014-02-19       Impact factor: 2.031

View more
  1 in total

1.  Risk of intraoperative floppy iris syndrome among selective alpha-1 blockers-A consistency model of 6,488 cases.

Authors:  Ya-Hui Wang; Liang-Chen Huang; Sung Huang Laurent Tsai; Ying-Jen Chen; Chien-Liang Wu; Yi-No Kang
Journal:  Front Med (Lausanne)       Date:  2022-08-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.